Access cutting-edge pediatric cancer treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access pediatric cancer specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pediatric cancer treatment provided free
Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood cancers) that are any of these: * Advanced, which means cancer spread in the body or cannot be removed with surgery * Relapsed, which means cancer has come back after it had responded to previous treatment (responded means it stopped growing, gets smaller, or disappeared) * Refractory, which means cancer did not respond to previous treatment Pembrolizumab is
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this pediatric cancer clinical trial in New York, NY
If you're searching for pediatric cancer treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pediatric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.